BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17006609)

  • 21. Prognostic factors for radical resection of middle and distal bile duct cancer.
    Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
    Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymph node metastasis of patients with intrahepatic cholangiocarcinoma].
    Chen Z; Yan JJ; Huang L; Wu MC; Yan YQ
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):454-7. PubMed ID: 16772078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.
    Petrova E; Rückert F; Zach S; Shen Y; Weitz J; Grützmann R; Wittel UA; Makowiec F; Hopt UT; Bronsert P; Kühn F; Rau BM; Izrailov RE; Khatkov IE; Lapshyn H; Bolm L; Bausch D; Keck T; Wellner UF; Seifert G
    Langenbecks Arch Surg; 2017 Aug; 402(5):831-840. PubMed ID: 28612115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of portal vein invasion of distal cholangiocarcinoma as borderline resectability.
    Miura F; Sano K; Amano H; Toyota N; Wada K; Yoshida M; Hayano K; Matsubara H; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Apr; 22(4):294-300. PubMed ID: 25546148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
    Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
    HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up.
    Andrianello S; Paiella S; Allegrini V; Ramera M; Pulvirenti A; Malleo G; Salvia R; Bassi C
    Langenbecks Arch Surg; 2015 Jul; 400(5):623-8. PubMed ID: 26134446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.
    Kawai M; Tani M; Kobayashi Y; Tsuji T; Tabuse K; Horiuchi T; Oka M; Yamaguchi K; Sakata Y; Shimomura T; Yamaue H
    Am J Surg; 2010 Apr; 199(4):447-52. PubMed ID: 19596119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors after pancreatoduodenectomy for distal bile duct cancer.
    Qiao QL; Zhang TP; Guo JC; Zhan HX; Zhao JX; Liu YC; Wan YL; Leng XS; Zhao YP
    Am Surg; 2011 Nov; 77(11):1445-8. PubMed ID: 22196654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
    Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
    BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.
    Sierzega M; Bobrzyński Ł; Matyja A; Kulig J
    World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.